Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
Kate Skolnik(University of Calgary), Michael D. Parkins(University of Calgary), Harvey Rabin(University of Calgary), Austin Nguyen(University of Calgary), Tyler Williamson(University of Calgary), Barbara J. Waddell(University of Calgary), Christina S. Thornton(Alberta Health Services)
Cited by 11
Related Papers
Adverse childhood experiences: a meta‐analysis of prevalence and moderators among half a million adults in 206 studies
|World Psychiatry|2023|360
Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response
|Frontiers in Immunology|2024|52
Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values
|Antimicrobial Resistance and Infection Control|2022|47
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
|European Respiratory Review|2021|45